HAEMONETICS
HAEMONETICS operates in Diversified Metals & Mining.
Market Cap & Net Worth: HAEMONETICS (HAZ)
HAEMONETICS (MU:HAZ) has a market capitalization of $490.47K (€477.82K) as of March 19, 2026. Listed on the MU stock exchange, this Germany-based company holds position #37439 globally and #4825 in its home market, demonstrating a -4.95% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying HAEMONETICS's stock price €52.60 by its total outstanding shares 9084 (9.08K).
HAEMONETICS Market Cap History: 2015 to 2026
HAEMONETICS's market capitalization history from 2015 to 2026. Data shows growth from $278.15K to $490.47K (6.11% CAGR).
HAEMONETICS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how HAEMONETICS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
HAEMONETICS's market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.01x
HAEMONETICS's market cap is 0.01 times its annual earnings
0.00x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $453.96K | $886.12 Million | -$26.27 Million | 0.00x | N/A |
| 2018 | $778.59K | $903.92 Million | $45.57 Million | 0.00x | 0.02x |
| 2019 | $969.75K | $967.58 Million | $55.02 Million | 0.00x | 0.02x |
| 2020 | $904.47K | $988.48 Million | $76.53 Million | 0.00x | 0.01x |
| 2021 | $445.71K | $870.46 Million | $79.47 Million | 0.00x | 0.01x |
| 2022 | $690.01K | $993.20 Million | $43.38 Million | 0.00x | 0.02x |
| 2023 | $736.63K | $1.17 Billion | $115.40 Million | 0.00x | 0.01x |
| 2024 | $704.00K | $1.31 Billion | $117.56 Million | 0.00x | 0.01x |
Competitor Companies of HAZ by Market Capitalization
Companies near HAEMONETICS in the global market cap rankings as of March 19, 2026.
Key companies related to HAEMONETICS by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2328 globally with a market cap of $6.43 Billion USD ( €6.27 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2395 globally with a market cap of $6.17 Billion USD ( €6.02 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3760 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4660 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2328 | BERKSHIRE HATH-A | BE:BRH | $6.43 Billion | €634500.00 |
| #2395 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.17 Billion | €638000.00 |
| #3760 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4660 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
HAEMONETICS Historical Marketcap From 2015 to 2026
Between 2015 and today, HAEMONETICS's market cap moved from $278.15K to $ 490.47K, with a yearly change of 6.11%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €490.47K | -23.77% |
| 2025 | €643.39K | -8.61% |
| 2024 | €704.00K | -4.43% |
| 2023 | €736.63K | +6.76% |
| 2022 | €690.01K | +54.81% |
| 2021 | €445.71K | -50.72% |
| 2020 | €904.47K | -6.73% |
| 2019 | €969.75K | +24.55% |
| 2018 | €778.59K | +71.51% |
| 2017 | €453.96K | +27.38% |
| 2016 | €356.38K | +28.13% |
| 2015 | €278.15K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of HAEMONETICS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $490.47K USD |
| MoneyControl | $490.47K USD |
| MarketWatch | $490.47K USD |
| marketcap.company | $490.47K USD |
| Reuters | $490.47K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.